Anti-commercial bribery commitment

In order to further standardize the production and operation of medicines and medical devices, maintain fair competition, and maintain the healthy and orderly development of the pharmaceutical industry and the fundamental interests of the people. Special commitments are as follows:
First, strictly abide by the law and relevant laws and regulations, and conduct legitimate business contacts.
Second, in the process of marketing drugs and medical devices, medical institutions and staff, medical staff are not given kickbacks, commissions, etc. in various names.
Third, in the process of drug, medical device wholesale, retail, raw material procurement, advertising, participation in drugs, medical equipment bidding, do not take unfair means to obtain business opportunities or commercial interests.
4. In the key supervision links such as review, approval, certification, certification, inspection and inspection, and inspection and punishment of drugs and medical devices, the qualifications for access shall not be obtained by improper means, and the punishment shall be mitigated or evaded.
5. Do not use improper means to bring their products into the medical insurance catalogue, falsely report the cost and increase the price of the drug to obtain business opportunities or commercial interests.
6. Don't give gifts, cash, securities, and arrange high-end banquets, high-consumption entertainment, and tourism activities to food and drug supervision system staff.
The above commitments will be publicized to the public from the date of signing and will be supervised by people from all walks of life.
Ankang Food and Drug Administration Governance Commercial Bribery Leading Group Committed Unit:
Team leader: